Vnitr Lek 2006, 52(5):481-484

Rheumatologic manifestations in diabetes

J. Vencovský
Revmatologický ústav, Praha, ředitel prof. MUDr. Karel Pavelka, DrSc.

Patients with diabetes mellitus may encounter various musculoskeletal complications. Typical manifestations can be seen in the hand, such as limited joint mobility, flexor tendon synovitis, Dupuytren's contracture and carpal tunnel syndrome. Humeral periarthropathy is also more frequent. The most serious complications can occur in the form of diabetic foot, which may lead to severe deformities and disability. Diabetic amyotrophy and muscle infarction are more rare complications. While osteopenia has a well recognized association with type I diabetes mellitus, this probably is not true for type II. Similarly, the association between diabetes mellitus and osteoarthritis has not been proven.

Keywords: diabetes mellitus; joint manifestations; diabetic foot

Received: September 7, 2005; Accepted: September 7, 2005; Published: May 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vencovský J. Rheumatologic manifestations in diabetes. Vnitr Lek. 2006;52(5):481-484.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kapoor A, Sibbitt WL jr. Contractures in diabetes mellitus: the syndrome of limited joint mobility. Semin Arthritis Rheum 1989; 18: 168-180. Go to original source... Go to PubMed...
    2. Lindsay JR, Kennedy L, Atkinson AB et al. Reduced prevalence of limited joint mobility in type 1 diabetes in a U.K. clinic population over a 20-year period. Diabetes Care 2005; 28: 658-661. Go to original source... Go to PubMed...
    3. Eaton RP, Sibbitt WL jr, Shah VO et al. A commentary on 10 years of aldose reductase inhibition for limited joint mobility in diabetes. J Diabetes Complications 1998; 12: 34-38. Go to original source... Go to PubMed...
    4. Sibbitt WL jr, Eaton RP. Corticosteroid responsive tenosynovitis is a common pathway for limited joint mobility in the diabetic hand. J Rheumatol 1997; 24: 931-936. Go to PubMed...
    5. Bland JH, Frymoyer JW, Newberg AH et al. Rheumatic syndromes in endocrine disease. Semin Arthritis Rheum 1979; 9: 23-65. Go to original source... Go to PubMed...
    6. Arkkila PE, Kantola IM, Viikari JS et al. Shoulder capsulitis in type I and II diabetic patients: association with diabetic complications and related diseases. Ann Rheum Dis 1996; 55: 907-914. Go to original source... Go to PubMed...
    7. Vencovský J, Broulík P. The endocrine system. In: Isenberg DA, Maddison PJ et al. Oxford Textbook of Rheumatology. 3rd ed. Oxford: Oxford University Press 2004: 185-192.
    8. Fogács SS. Diabetes mellitus. In: Hochberg MC, Silman AJ et al. Rheumatology. 3rd ed. London: Elsevier Mosby 2003: 1977-1982.
    9. Sinha S, Munichoodappa CS, Kozak GP. Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 1972; 51: 191-210. Go to original source... Go to PubMed...
    10. Cavanagh PR, Young MJ, Adams JE et al. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 1994; 17: 201-209. Go to original source... Go to PubMed...
    11. Armstrong DG, Peters EJ. Charcot's arthropathy of the foot. J Am Podiatr Med Assoc 2002; 92: 390-394. Go to original source... Go to PubMed...
    12. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999; 38: 34-40. Go to original source... Go to PubMed...
    13. Jude EB, Selby PL, Burgess J et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001; 44: 2032-2037. Go to original source... Go to PubMed...
    14. Sella EJ, Grosser DM. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg 2003; 20: 729-740. Go to original source... Go to PubMed...
    15. Coppack SW, Watkins PJ. The natural history of diabetic femoral neuropathy. Q J Med 1991; 79: 307-313.
    16. Silberstein L, Britton KE, Marsh FP et al. An unexpected cause of muscle pain in diabetes. Ann Rheum Dis 2001; 60: 310-312. Go to original source... Go to PubMed...
    17. Melchior TM, Sorensen H, Torp-Pedersen C. Hip and distal arm fracture rates in peri- and postmenopausal insulin-treated diabetic females. J Intern Med 1994; 236: 203-208. Go to original source... Go to PubMed...
    18. van Daele PL, Stolk RP, Burger H et al. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med 1995; 122: 409-414. Go to original source... Go to PubMed...
    19. Frey MI, Barrett-Connor E, Sledge PA et al. The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 1996; 23: 716-722. Go to PubMed...
    20. Horn CA, Bradley JD, Brandt KD et al. Impairment of osteophyte formation in hyperglycemic patients with type II diabetes mellitus and knee osteoarthritis. Arthritis Rheum 1992; 35: 336-342. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.